Arkema


Sustained profitability despite lower sales prices

14/05/24 -"Sales in the Q1 declined as anticipated, but adjusted EBITDA demonstrated greater resilience. The figures were mixed compared to the consensus (sales: -2.0%; adjusted EBITDA: +2.6%; adjusted EPS: ..."

Pages
57
Language
English
Published on
14/05/24
You may also be interested by these reports :
19/06/24
We expect FY23/24 to be positive and 2H-weighted

18/06/24
Re-focusing on profitable growth & cash flow

12/06/24
Umicore’s new CEO, Bart Sap, had a challenging start without a 100-day grace period. He had to revise the recently confirmed FY guidance (26/04/2024) ...

28/05/24
Positive 1H: on track to meet FY targets

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO